KARACHI: A medicine prescribed for a type of blood cancer has been found to effectively cut down the need for blood transfusion in thalassaemia patients without any side effects, scientists at the National Institute of Blood Diseases (NIBD) are reporting.
The study was inspired by a research published in 2003 in the Blood journal that involved seven Algerian thalassaemia patients, who showed marked reduction in amount of blood transfused when given Hydroxyurea.
Thalassaemia is an
No comments:
Post a Comment